Does statin treatment improve postprandial hypertriglyceridemia in individuals at high-/very high-risk for ASCVD?
Individuals at high-/very high-risk for ASCVD
Statin treatment
Postprandial hypertriglyceridemia (pTG concentration)surrogate
Statin therapy effectively normalizes postprandial hypertriglyceridemia in a majority of high-risk ASCVD patients, including those with normal fasting triglycerides.
Nearly 30% of individuals at high-/very high-risk for ASCVD had postprandial hypertriglyceridemia. Statin treatment normalized abnormal postprandial lipemia in 75.6% of participants, and decreased pTG concentration even in those with normal fTG levels.
Building similarity graph...
Analyzing shared references across papers
Loading...
Kolovou et al. (Wed,) studied this question.
synapsesocial.com/papers/69a75a6fc6e9836116a20403 — DOI: https://doi.org/10.2174/0115701611390916251104053059
Genovefa D. Kolovou
Theodoros Katsikas
Petros Kalogeropoulos
Current Vascular Pharmacology
University College London
Brigham and Women's Hospital
National and Kapodistrian University of Athens
Building similarity graph...
Analyzing shared references across papers
Loading...